{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:56:02Z","timestamp":1788314162841,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T00:00:00Z","timestamp":1686096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Adjuvant therapy prolongs survival in patients with pancreatic ductal adenocarcinoma. However, no clear guidelines are available regarding the oncologic effects of adjuvant therapy (AT) in resected invasive intraductal papillary mucinous neoplasms (IPMN). The aim was to investigate the potential role of AT in patients with resected invasive IPMN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>From 2001 to 2020, 332 patients with invasive pancreatic IPMN were retrospectively reviewed in 15 centres in eight countries. Propensity score-matched and stage-matched survival analyses were conducted.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 289 patients were enroled in the study after exclusion (neoadjuvant therapy, unresectable disease, uncertain AT status, and stage IV). A total of 170 patients were enroled in a 1:1 propensity score-matched analysis according to the covariates. In the overall cohort, disease-free survival was significantly better in the surgery alone group than in the AT group (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.003), but overall survival (OS) was not (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.579). There were no significant differences in OS in the stage-matched analysis between the surgery alone and AT groups (stage I, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.402; stage II, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.179). AT did not show a survival benefit in the subgroup analysis according to nodal metastasis (N0, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.481; N+, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.705). In multivariate analysis, node metastasis (hazard ratio, 4.083; 95% CI, 2.408\u22126.772, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and cancer antigen 19-9 greater than or equal to 100 (hazard ratio, 2.058; 95% CI, 1.247\u22123.395, <jats:italic toggle=\"yes\">P<\/jats:italic>=0.005) were identified as adverse prognostic factors in resected invasive IPMN.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The current AT strategy may not be recommended to be performed with resected invasive IPMN in stage I and II groups, unlike pancreatic ductal adenocarcinoma. Further investigations of the potential role of AT in invasive IPMN are recommended.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/js9.0000000000000537","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T18:00:14Z","timestamp":1686420014000},"page":"2906-2913","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas: an international multicenter cohort study"],"prefix":"10.1097","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-4747","authenticated-orcid":false,"given":"Munseok","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Surgery, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin-si, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-E","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Taipei Veterans General Hospital, National Yang Ming University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Seong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gangnam Severance Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung Sun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Surgery, Gangnam Severance Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hoon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Surgery, CHA Bundang Medical Center, CHA University, Seongam-si, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Uk","family":"Chong","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nagakawa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Pediatric Surgery, Tokyo Medical University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Surgery, Teikyo University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sunagawa","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Nakagami Hospital, Okinawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby VM","family":"Dasari","sequence":"additional","affiliation":[{"name":"Department of HPB and Liver Transplantation, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Ming","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Lip","family":"Seng","sequence":"additional","affiliation":[{"name":"Hepatopancreatobiliary Unit, Department of General Surgery, Changi General Hospital, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-1598","authenticated-orcid":false,"given":"Heiner","family":"Wolters","sequence":"additional","affiliation":[{"name":"Department of Visceral and General Surgery, St. Josefs-Hospital, Dortmund, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unenbat","family":"Gurbadam","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Cancer Center Hospital, Ulan Bator, Mongolia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byoung UK","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of California, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Winslow","sequence":"additional","affiliation":[{"name":"Department of Pathology, The University of California, San Francisco, CA"},{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fishbein","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hawksworth","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pejman","family":"Radkani","sequence":"additional","affiliation":[{"name":"MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5382-4658","authenticated-orcid":false,"given":"Chang Moo","family":"Kang","sequence":"additional","affiliation":[{"name":"Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,10]]},"reference":[{"key":"R1-20250824","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.suc.2016.07.009","article-title":"Intraductal papillary mucinous neoplasm of the pancreas","volume":"96","author":"Fong","year":"2016","journal-title":"Surg Clin North Am"},{"key":"R2-20250824","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2011.12.029","article-title":"The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm","volume":"10","author":"Klibansky","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R3-20250824","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000090023","article-title":"International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas","volume":"6","author":"Tanaka","year":"2006","journal-title":"Pancreatology"},{"key":"R4-20250824","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","article-title":"International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas","volume":"12","author":"Tanaka","year":"2012","journal-title":"Pancreatology"},{"key":"R5-20250824","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.pan.2017.07.007","article-title":"Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas","volume":"17","author":"Tanaka","year":"2017","journal-title":"Pancreatology"},{"key":"R6-20250824","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/SLA.0000000000001985","article-title":"Proposed nomogram predicting the individual risk of malignancy in the patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas","volume":"266","author":"Jang","year":"2017","journal-title":"Ann Surg"},{"key":"R7-20250824","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jhbp.962","article-title":"Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: an international multicenter study","volume":"30","author":"Kim","year":"2023","journal-title":"J Hepato-Biliary-Pancreatic Sci"},{"key":"R8-20250824","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1245\/s10434-018-6425-6","article-title":"What is the incidence of malignancy in resected intraductal papillary mucinous neoplasms? An analysis of over 100 US institutions in a single year","volume":"25","author":"Khoury","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R9-20250824","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/srep00161","article-title":"Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas","volume":"1","author":"Furukawa","year":"2011","journal-title":"Sci Rep"},{"key":"R10-20250824","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.3390\/ijms22136756","article-title":"Intraductal papillary mucinous carcinoma versus conventional pancreatic ductal adenocarcinoma: a comprehensive review of clinical-pathological features, outcomes, and molecular insights","volume":"22","author":"Mas","year":"2021","journal-title":"Int J Molecular Sci"},{"key":"R11-20250824","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jhbp.996","article-title":"Role of postoperative adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas: a multicenter external validation","volume":"28","author":"Choi","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"R12-20250824","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N Engl J Med"},{"key":"R13-20250824","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2009.02.071","article-title":"Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas","volume":"76","author":"Swartz","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20250824","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1477-2574.2010.00196.x","article-title":"Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy","volume":"12","author":"Turrini","year":"2010","journal-title":"HPB (Oxford)"},{"key":"R15-20250824","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ejso.2012.12.005","article-title":"Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms","volume":"39","author":"Caponi","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"R16-20250824","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cncr.29803","article-title":"The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN)","volume":"122","author":"McMillan","year":"2016","journal-title":"Cancer"},{"key":"R17-20250824","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hpb.2018.09.013","article-title":"Adjuvant chemotherapy is associated with improved postoperative survival in specific subtypes of invasive intraductal papillary mucinous neoplasms (IPMN) of the pancreas: it is time for randomized controlled data","volume":"21","author":"Marchegiani","year":"2019","journal-title":"HPB (Oxford)"},{"key":"R18-20250824","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.pan.2020.03.009","article-title":"Impact of adjuvant therapy in patients with invasive intraductal papillary mucinous neoplasms of the pancreas","volume":"20","author":"Rodrigues","year":"2020","journal-title":"Pancreatology"},{"key":"R19-20250824","doi-asserted-by":"crossref","first-page":"100430","DOI":"10.1016\/j.ijso.2021.100430","article-title":"STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"37","author":"Mathew","year":"2021","journal-title":"Int J Surg Open"},{"key":"R20-20250824","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/01.sla.0000128306.90650.aa","article-title":"Intraductal papillary mucinous neoplasms of the pancreas: an updated experience","volume":"239","author":"Sohn","year":"2004","journal-title":"Ann Surg"},{"key":"R21-20250824","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1002\/cncr.25070","article-title":"Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes","volume":"116","author":"Wasif","year":"2010","journal-title":"Cancer"},{"key":"R22-20250824","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1245\/s10434-014-3639-0","article-title":"Systematic review and meta-analysis comparing the surgical outcomes of invasive intraductal papillary mucinous neoplasms and conventional pancreatic ductal adenocarcinoma","volume":"21","author":"Koh","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"R23-20250824","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijsu.2019.09.014","article-title":"Intraductal papillary mucinous carcinoma versus pancreatic ductal adenocarcinoma: a systematic review and meta-analysis","volume":"71","author":"Aronsson","year":"2019","journal-title":"Int J Surg"},{"key":"R24-20250824","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1245\/s10434-020-08916-6","article-title":"Controversial role of adjuvant therapy in node-negative invasive intraductal papillary mucinous neoplasm","volume":"28","author":"Mungo","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"R25-20250824","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.3390\/cancers15061722","article-title":"The role of genetic, metabolic, inflammatory, and immunologic mediators in the progression of intraductal papillary mucinous neoplasms to pancreatic adenocarcinoma","volume":"15","author":"Shockley","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R26-20250824","doi-asserted-by":"crossref","first-page":"102714","DOI":"10.1016\/j.ebiom.2020.102714","article-title":"Evolution of the immune landscape during progression of pancreatic intraductal papillary mucinous neoplasms to invasive cancer","volume":"54","author":"Roth","year":"2020","journal-title":"EBioMedicine"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T19:05:16Z","timestamp":1756062316000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000000537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000000537","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,7]]},"assertion":[{"value":"2023-03-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}